Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Inclusion Criteria: * Healthy male and female full-term (37-42 weeks gestation) neonates (birth to 10 days of age) * Born to mothers with documented negative test for HBsAg within 9 months prior to delivery Exclusion Criteria: * Infant born to mother with no prenatal care * Known or suspected impairment of immunologic function * Prior vaccination with any hepatitis B vaccine for infant or mother(within 6 months prior to the birth of infant.) * Recent(\<72 hours) history of febrile illness \>/= 99.5 degrees F (\>/= 37.5 degrees C) axillary or \>/= 100.5 degrees F (\>/= 38.1 degrees C) rectal * Any prior administration of hepatitis B immune globulin (HBIG), serum immune globulin, or any other blood-derived product, or the receipt by the mother of either immunoglobulin or HBIG within 6 months prior to birth of the infant * Receipt of investigational vaccines by mother or infant within 3 months prior to first injection with study vaccine or if scheduled to be given to the infant during the study * Known or suspected hypersensitivity to any component of study vaccine (e.g., aluminum, yeast) * Any infant who cannot be adequately followed for study visits during the course of the clinical study * Any condition that in the opinion of the investigator, may interfere with the evaluation of study objectives